First human test of new brain disorder pill begins
NCT ID NCT06300398
Summary
This was an early-stage study to check the safety of a new oral drug called IAMA-6 in healthy adults. Researchers gave 72 healthy volunteers single and multiple doses to see how their bodies handled the drug and to identify any side effects. The goal was to gather basic safety information to see if the drug could be studied further for conditions like neurodevelopmental disorders.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEURODEVELOPMENTAL DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Ricerche Cliniche Di Verona S.r.l.
Verona, Italy
Conditions
Explore the condition pages connected to this study.